![PROFID](/img/default-banner.jpg)
- Видео 8
- Просмотров 629
PROFID
Добавлен 30 сен 2020
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 847999.
The aim of PROFID is to develop a personalized prediction of risk for sudden cardiac death after myocardial infarction, a leading cause of death in Europe, as well as a personalized sudden cardiac death prevention by targeted implantation of an implantable cardioverter-defibrillator. The ultimate goal is to successfully prevent the majority of the catastrophic sudden cardiac death events that occur after myocardial infarction by accurate and timely identification of those patients that are at high risk for sudden cardiac death (based on multiple factors, over and above LVEF, including relevant clinical characteristics/biomarkers) followed by implantable cardioverter defibrillator implantation. Thus, PROFID aims to close the huge gap of current clinical practice with regard to protection from sudden cardiac death after myocardial infarction.
The aim of PROFID is to develop a personalized prediction of risk for sudden cardiac death after myocardial infarction, a leading cause of death in Europe, as well as a personalized sudden cardiac death prevention by targeted implantation of an implantable cardioverter-defibrillator. The ultimate goal is to successfully prevent the majority of the catastrophic sudden cardiac death events that occur after myocardial infarction by accurate and timely identification of those patients that are at high risk for sudden cardiac death (based on multiple factors, over and above LVEF, including relevant clinical characteristics/biomarkers) followed by implantable cardioverter defibrillator implantation. Thus, PROFID aims to close the huge gap of current clinical practice with regard to protection from sudden cardiac death after myocardial infarction.
EHRA Snacks with Nikos Dagres, Prash Sanders and Rodrigue Garcia,
#EHRAsnacks at hashtag#EHRA2024
Get the latest on:
🔵 risk stratification for hashtag#SuddenCardiacDeath from Nikos Dagres
🔵risk factor management for hashtag#AtrialFibrillation from Prashanthan Sanders
Hosted by Rodrigue GARCIA
hashtag#EHRA_ESC hashtag#YoungEP hashtag#EPeeps
Get the latest on:
🔵 risk stratification for hashtag#SuddenCardiacDeath from Nikos Dagres
🔵risk factor management for hashtag#AtrialFibrillation from Prashanthan Sanders
Hosted by Rodrigue GARCIA
hashtag#EHRA_ESC hashtag#YoungEP hashtag#EPeeps
Просмотров: 45
Видео
The PROFID EHRA clinical trial
Просмотров 926 месяцев назад
The PROFID EHRA trial (NCT05665608) is set to answer the question if routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial infarction survivors with heart failure is still an adequate therapy for prevention of sudden cardiac death.
First patient enrolled in the PROFID EHRA trial
Просмотров 2759 месяцев назад
Prof. Dr. Gerhard Hindricks (Chief Investigator PROFID EHRA trial)
Assessing ICD implantation in MI survivors with LVEF ≤ 35% under OMT: The PROFID EHRA trial
Просмотров 16710 месяцев назад
Dr. Raphaela Kübeck, (CRO Project Director PROFID EHRA trial), Prof. Dr. Gerhard Hindricks (Chief Investigator PROFID EHRA trial), and Dr. Nikolaos Dagres (Chief Investigator PROFID EHRA trial) discussed at the ESC Congress 2023 the roll out of the PROFID EHRA clinical trial.
We are very proud to be the first center in Europe to be initiated. Thank you for the great collaboration!